AIRLINK 176.00 Decreased By ▼ -1.56 (-0.88%)
BOP 11.16 Increased By ▲ 0.11 (1%)
CNERGY 8.28 Increased By ▲ 0.11 (1.35%)
FCCL 47.95 Increased By ▲ 0.63 (1.33%)
FFL 16.39 Increased By ▲ 0.27 (1.67%)
FLYNG 27.23 Decreased By ▼ -0.12 (-0.44%)
HUBC 144.11 Decreased By ▼ -2.80 (-1.91%)
HUMNL 13.65 Increased By ▲ 0.14 (1.04%)
KEL 4.49 Decreased By ▼ -0.01 (-0.22%)
KOSM 5.94 Increased By ▲ 0.03 (0.51%)
MLCF 62.85 Increased By ▲ 0.83 (1.34%)
OGDC 231.00 Decreased By ▼ -3.68 (-1.57%)
PACE 5.83 Increased By ▲ 0.03 (0.52%)
PAEL 45.50 Decreased By ▼ -0.91 (-1.96%)
PIAHCLA 17.95 Decreased By ▼ -0.17 (-0.94%)
PIBTL 10.68 Increased By ▲ 0.11 (1.04%)
POWER 12.06 Increased By ▲ 0.07 (0.58%)
PPL 189.25 Decreased By ▼ -2.55 (-1.33%)
PRL 37.49 Increased By ▲ 0.17 (0.46%)
PTC 23.00 Decreased By ▼ -0.20 (-0.86%)
SEARL 101.00 Increased By ▲ 0.11 (0.11%)
SSGC 39.15 Decreased By ▼ -0.56 (-1.41%)
SYM 15.00 Decreased By ▼ -0.03 (-0.2%)
TELE 7.88 Increased By ▲ 0.04 (0.51%)
TPLP 11.15 Increased By ▲ 0.04 (0.36%)
TRG 66.10 Decreased By ▼ -1.19 (-1.77%)
WAVESAPP 11.13 Decreased By ▼ -0.22 (-1.94%)
WTL 1.36 No Change ▼ 0.00 (0%)
YOUW 3.83 Increased By ▲ 0.06 (1.59%)
BR100 12,912 Increased By 105.7 (0.83%)
BR30 39,345 Decreased By -358.5 (-0.9%)
KSE100 119,731 Increased By 792.8 (0.67%)
KSE30 37,075 Increased By 318.6 (0.87%)

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has officially announced implementation of Industry e-Reporting System for reporting of adverse drug reactions.

In an official communique directed to the chairman Pakistan Pharmaceutical Manufacturing Association (PPMA), the executive director (ED) Pharma Bureau and the chairman Pakistan Chemist and Druggist Association (PCDA), the DRAP said, following the completion of a successful pilot project on the subject engaging a selected group of registration holders has decided to extend its scope to all the registration holders.

Therefore, all the registration holders are hereby directed to submit all future Individual Case Safety Reports (ICSRs) only through the Industry e-Reporting System with effect from November 8, 2024.

This new system, developed in collaboration with the Uppsala Monitoring Centre (UMC), aims to simplify and streamline the submission process for registration holders, including manufacturers and importers of therapeutic goods.

The National Pharmacovigilance Centre (NPC) established under the Division of Pharmacy Services will oversee this initiative to ensure the safety of therapeutic goods, in line with the Pharmacovigilance Rules, 2022.

Since its inception, the DRAP has been committed to promoting transparency and facilitating document submission through various tools. The new Industry e-Reporting System will allow registration holders to submit ICSRs via two modules: E2B XML submission and manual data entry for non-E2B pharmaceutical companies. Access to this system will be secure, with two accounts provided per registration holder.

Following a successful pilot project with a selected number of registration holders, the DRAP is now extending the system’s scope to all registration holders.

Starting from 8th November 2024, all future ICSRs must be submitted through this system. Further guidelines are available on the DRAP’s website.

The DRAP will appreciate your cooperation in ensuring the safety and efficacy of therapeutic goods in Pakistan.

Copyright Business Recorder, 2024

Comments

Comments are closed.